# Volatile Anesthetic Protection Of Renal Transplants 2

> **NCT02727296** · PHASE4 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 488 (actual)

## Conditions studied

- Delayed Graft Function
- Renal Outcome After Kidney Transplantation
- Acute Rejection (AR) of Transplanted Kidney
- Graft Survival
- Patient Survival
- Postoperative Complications
- Length of Hospital Stay
- Primary Non Function

## Interventions

- **DRUG:** sevoflurane
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT02727296
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-01
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-01-31
- **Target enrollment:** 488 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02727296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02727296, "Volatile Anesthetic Protection Of Renal Transplants 2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02727296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*